Nuvalent, Inc. (NUVL)
107.72
-4.27
(-3.81%)
USD |
NASDAQ |
Jan 23, 14:13
Nuvalent Cash from Investing (Quarterly): 53.97M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Boston Scientific Corp. | -502.00M |
| Pfizer Inc. | -2.43B |
| Vanda Pharmaceuticals, Inc. | 21.36M |
| Xencor, Inc. | 14.67M |
| Glaukos Corp. | -3.993M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -70.46M |
| Cash from Financing (Quarterly) | 4.773M |
| Free Cash Flow | -263.88M |
| Free Cash Flow Per Share (Quarterly) | -0.9767 |
| Free Cash Flow to Equity (Quarterly) | -70.46M |
| Free Cash Flow to Firm (Quarterly) | -70.46M |
| Free Cash Flow Yield | -3.42% |